ATE497960T1 - A1-adenosinrezeptoragonisten - Google Patents

A1-adenosinrezeptoragonisten

Info

Publication number
ATE497960T1
ATE497960T1 AT06825861T AT06825861T ATE497960T1 AT E497960 T1 ATE497960 T1 AT E497960T1 AT 06825861 T AT06825861 T AT 06825861T AT 06825861 T AT06825861 T AT 06825861T AT E497960 T1 ATE497960 T1 AT E497960T1
Authority
AT
Austria
Prior art keywords
receptor agonists
adenosine receptor
angina
release
useful
Prior art date
Application number
AT06825861T
Other languages
English (en)
Inventor
Elfatih Elzein
Xiaofen Li
Jeff Zablocki
Original Assignee
Cv Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cv Therapeutics Inc filed Critical Cv Therapeutics Inc
Application granted granted Critical
Publication of ATE497960T1 publication Critical patent/ATE497960T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT06825861T 2005-10-13 2006-10-11 A1-adenosinrezeptoragonisten ATE497960T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72661605P 2005-10-13 2005-10-13
PCT/US2006/039975 WO2007047401A2 (en) 2005-10-13 2006-10-11 A1 adenosine receptor agonists

Publications (1)

Publication Number Publication Date
ATE497960T1 true ATE497960T1 (de) 2011-02-15

Family

ID=37865975

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06825861T ATE497960T1 (de) 2005-10-13 2006-10-11 A1-adenosinrezeptoragonisten

Country Status (8)

Country Link
US (2) US7488720B2 (de)
EP (1) EP1943251B8 (de)
JP (1) JP2009511593A (de)
AT (1) ATE497960T1 (de)
CA (1) CA2625783A1 (de)
DE (1) DE602006020057D1 (de)
ES (1) ES2358351T3 (de)
WO (1) WO2007047401A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007047401A2 (en) * 2005-10-13 2007-04-26 Cv Therapeutics, Inc. A1 adenosine receptor agonists
CN101712709A (zh) * 2008-10-06 2010-05-26 中国医学科学院药物研究所 三乙酰基-3-羟基苯基腺苷及其调血脂的用途
RU2765286C2 (ru) * 2017-05-19 2022-01-28 Оллтек, Инк. Фармацевтические агенты, композиции и способы, относящиеся к ним
JP2025520300A (ja) * 2022-06-17 2025-07-03 上海森輝医薬有限公司 シクロペンチルアデノシン誘導体及びその医薬的使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4326525A (en) * 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
US5364620A (en) 1983-12-22 1994-11-15 Elan Corporation, Plc Controlled absorption diltiazem formulation for once daily administration
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US4992445A (en) * 1987-06-12 1991-02-12 American Cyanamid Co. Transdermal delivery of pharmaceuticals
US4902514A (en) * 1988-07-21 1990-02-20 Alza Corporation Dosage form for administering nilvadipine for treating cardiovascular symptoms
AU5879299A (en) 1998-10-16 2000-05-08 Monaghan, Sandra Marina Adenine derivatives
US20030013675A1 (en) * 2001-05-25 2003-01-16 Boehringer Ingelheim Pharma Kg Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
US20030078232A1 (en) * 2001-08-08 2003-04-24 Elfatih Elzein Adenosine receptor A3 agonists
NZ541651A (en) 2003-02-03 2009-01-31 Cv Therapeutics Inc Partial and full agonists of A1 adenosine receptors
WO2007047401A2 (en) * 2005-10-13 2007-04-26 Cv Therapeutics, Inc. A1 adenosine receptor agonists

Also Published As

Publication number Publication date
US7488720B2 (en) 2009-02-10
WO2007047401A3 (en) 2007-06-14
WO2007047401A2 (en) 2007-04-26
EP1943251B8 (de) 2011-03-23
CA2625783A1 (en) 2007-04-26
DE602006020057D1 (de) 2011-03-24
ES2358351T8 (es) 2011-06-15
EP1943251A2 (de) 2008-07-16
JP2009511593A (ja) 2009-03-19
EP1943251B1 (de) 2011-02-09
ES2358351T3 (es) 2011-05-09
US20090137520A1 (en) 2009-05-28
US20070087994A1 (en) 2007-04-19

Similar Documents

Publication Publication Date Title
EA201270300A1 (ru) Визуализация и оценка эмбрионов, яйцеклеток и стволовых клеток
EA200970519A1 (ru) Полиморфы сукцината 2-[6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2h-пиримидин-1-илметил]-4-фторбензонитрил и способы их применения
EA200800100A1 (ru) Соединения азаиндазола и способы применения
CL2009001476A1 (es) Compuestos derivados de 2,4-diamin-n2-fenil pirimidina sustituidos, mediadores de la inhibicion de igf-1r; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de enfermedades autoinmune, por trasplante, infecciosas o un trastorno proliferativo celular.
EA200800727A1 (ru) Введение ингибиторов дипептидилпептидазы
Ligasová et al. A fatal combination: a thymidylate synthase inhibitor with DNA damaging activity
ECSP077836A (es) Compuestos mejorados farmacocinéticamente
NO20081211L (no) Xantinderivater som selektive HM74A agonister
CL2011000978A1 (es) Compuestos derivados de fenil-amida o piridil-amida, agonistas de gpbar1; proceso de preparacion; composicion farmaceutica; y su uso en diabetes, isquemia, obesidad, dislipidemia, entre otras.
DK1948822T3 (da) Multikomponent-nukleinsyreenzymer og fremgangsmåder til deres anvendelse
TW200732347A (en) VEGF analogs and methods of use
NO20082240L (no) GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
WO2004069185A3 (en) Partial and full agonists of a1 adenosine receptors
FR2924118B1 (fr) Fragments d'anticorps inhibiteurs de la proteine nef du vih.
EA201270204A1 (ru) Таблетка
ATE497960T1 (de) A1-adenosinrezeptoragonisten
TW200616649A (en) Partial and full agonists of A1 adenosine receptors
CL2011001496A1 (es) Compuestos derivados de 2-piridin-2-il-pirazol-3(2h)-ona, activadores de hif; composicion farmaceutica que los comprende; procedimiento de preparacion de estos; y su uso en el tratamiento de enfermedades cardiacas perifericas de origen isquemico, entre otras.
TW200621793A (en) Partial and full agonists of a1 adenosine receptors
FR2889976B1 (fr) Appaeil de traitement par voie humide.
ECSP088994A (es) INHIBIDORES DE CANAL DE POTASIO Kv1.5
WO2006116197A3 (en) Methods of identifying individuals at risk of perioperative myocardial injury, major adverse cardiac events, cognitive decline, arrhythmias, depression or bleeding
TH83828B (th) ชิ้นส่วนรองเท้า
BRPI0602614A (pt) utilização de amido desramificado na extrusão - esferonização de pelotas farmacêuticas
TH86879B (th) หน้าตัดโลหะ

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1943251

Country of ref document: EP